Potential of E3 Ubiquitin Ligases in Cancer Immunity: Opportunities and Challenges

Cancer immunotherapies, including immune checkpoint inhibitors and immune pathway–targeted therapies, are promising clinical strategies for treating cancer. However, drug resistance and adverse reactions remain the main challenges for immunotherapy management. The future direction of immunotherapy i...

Descripción completa

Detalles Bibliográficos
Autores principales: Ye, Peng, Chi, Xiaoxia, Cha, Jong-Ho, Luo, Shahang, Yang, Guanghui, Yan, Xiuwen, Yang, Wen-Hao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699390/
https://www.ncbi.nlm.nih.gov/pubmed/34943817
http://dx.doi.org/10.3390/cells10123309

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699390/
https://www.ncbi.nlm.nih.gov/pubmed/34943817
http://dx.doi.org/10.3390/cells10123309

Ejemplares similares